4.4 Article

HEY1-mediated cisplatin resistance in lung adenocarcinoma via epithelial-mesenchymal transition

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Acquisition of paclitaxel resistance modulates the biological traits of gastric cancer AGS cells and facilitates epithelial to mesenchymal transition and angiogenesis

Ali Niapour et al.

Summary: This study successfully developed PTX-resistant AGS-R cells, exhibiting resistance to multiple drugs and alterations in key signaling pathways related to survival, EMT, and angiogenesis.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2022)

Article Oncology

Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma

Takahito Fukusumi et al.

Summary: The study found that in head and neck squamous cell carcinoma, HEY1 promotes EMT by upregulating SOX2 expression and forming a positive reciprocal feedback loop. HEY1 also regulates NOTCH4 expression, enhancing the specific upregulation of this pathway.

INTERNATIONAL JOURNAL OF ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis

Wei-Hsin Lin et al.

Summary: The research suggests that BM-MSC plays a crucial role in cancer cell dissemination and metastasis in lung cancer models. BM-MSC-induced signaling triggers early dissemination of cancer stem cells and promotes proliferation at secondary sites. Additionally, intercellular signaling regulates the switch between migration and proliferation.

ONCOGENE (2021)

Review Oncology

Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pie-ces of an Incomplete Puzzle for Lung Cancer Therapy

Milad Ashrafizadeh et al.

Summary: Long non-coding RNAs (lncRNAs) play a crucial role in regulating epithelial-to-mesenchymal transition (EMT) in lung cancer. Some lncRNAs have tumor-suppressing effects by inhibiting EMT and metastasis, while others have tumor-promoting effects by triggering EMT and enhancing migration of cancer cells. Targeting lncRNAs could be important in controlling the migration of lung cancer cells.

CURRENT CANCER DRUG TARGETS (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Biotechnology & Applied Microbiology

Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC

Yunyao Ye et al.

ONCOTARGETS AND THERAPY (2020)

Review Cell Biology

PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy

Fatemeh K. Dermani et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Biochemistry & Molecular Biology

Cisplatin: The first metal based anticancer drug

Sumit Ghosh

BIOORGANIC CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

HR23A-knockdown lung cancer cells exhibit epithelial-to-mesenchymal transition and gain sternness properties through increased Twist1 stability

Chung-Yun Yu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)

Review Biochemistry & Molecular Biology

The Nefarious Nexus of Noncoding RNAs in Cancer

Eleni Anastasiadou et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Pharmacology & Pharmacy

Cisplatin resistance and opportunities for precision medicine

Lauren Amable

PHARMACOLOGICAL RESEARCH (2016)

Review Chemistry, Medicinal

Molecular mechanisms of cisplatin resistance in cervical cancer

Haiyan Zhu et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2016)

Review Pharmacology & Pharmacy

Cisplatin in cancer therapy: Molecular mechanisms of action

Shaloam Dasari et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2014)

Review Biochemistry & Molecular Biology

Molecular mechanisms of cisplatin resistance

L. Galluzzi et al.

ONCOGENE (2012)

Review Pathology

MicroRNAs in Cancer

Yong Sun Lee et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)

Review Medicine, Research & Experimental

The basics of epithelial-mesenchymal transition

Raghu Kalluri et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)